Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Jul;79(3):637–643. doi: 10.1111/j.1476-5381.1983.tb10000.x

Studies on the interaction between cerebral 5-hydroxytryptamine and gamma-aminobutyric acid in the mode of action of diazepam in the rat.

J Collinge, C J Pycock, P V Taberner
PMCID: PMC2044906  PMID: 6652347

Abstract

The effect of the benzodiazepine, diazepam, administered for 7 days in doses between 1.25 and 5 mg kg-1 was studied on the turnover of 5-hydroxytryptamine (5-HT) in rat cerebral cortex. 5-HT turnover was assessed by calculating the ratio of the concentration of the major metabolite 5-hydroxyindoleacetic acid (5-HIAA) to that of 5-HT (i.e., 5-HIAA:5-HT). Diazepam (2.5 and 5 mg kg-1 i.p. daily for 7 days) significantly reduced cerebral cortical 5-HT turnover. The effect of manipulating cerebral gamma-aminobutyric acid (GABA) mechanisms on this action of diazepam was studied. Treatment of animals with a subconvulsive dose of picrotoxin (3 mg kg-1 i.p.) reversed the fall in cortical 5-HT turnover seen following diazepam. In contrast, however, treatment with the GABA transaminase inhibitors, amino-oxyacetic acid (25 mg kg-1) or ethanolamine-O-sulphate (250 mg kg-1, 7 days) which elevated cerebral GABA concentrations, enhanced the reduction in cortical 5-HT turnover following diazepam. Focal injection of picrotoxin (0.1 micrograms) into the region of the dorsal raphé nucleus reversed the decrease in cortical 5-HT turnover caused by diazepam. The hypothesis that doses of diazepam which result in total plasma concentrations comparable to those observed in man produce a reduction in 5-HT turnover mediated via GABA neurones is discussed.

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belin M. F., Aguera M., Tappaz M., McRae-Degueurce A., Bobillier P., Pujol J. F. GABA-accumulating neurons in the nucleus raphe dorsalis and periaqueductal gray in the rat: a biochemical and radioautographic study. Brain Res. 1979 Jul 13;170(2):279–297. doi: 10.1016/0006-8993(79)90107-0. [DOI] [PubMed] [Google Scholar]
  2. Bobillier P., Seguin S., Petitjean F., Salvert D., Touret M., Jouvet M. The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography. Brain Res. 1976 Sep 3;113(3):449–486. doi: 10.1016/0006-8993(76)90050-0. [DOI] [PubMed] [Google Scholar]
  3. Braestrup C., Albrechtsen R., Squires R. F. High densities of benzodiazepine receptors in human cortical areas. Nature. 1977 Oct 20;269(5630):702–704. doi: 10.1038/269702a0. [DOI] [PubMed] [Google Scholar]
  4. Chase T. N., Katz R. I., Kopin I. J. Effect of diazepam on fate of intracisternally injected serotonin-C14. Neuropharmacology. 1970 Mar;9(2):103–108. doi: 10.1016/0028-3908(70)90053-5. [DOI] [PubMed] [Google Scholar]
  5. Collins G. S. Effect of aminooxyacetic acid, thiosemicarbazide and haloperidol on the metabolism and half-lives of glutamate and GABA in rat brain. Biochem Pharmacol. 1973 Jan 1;22(1):101–111. doi: 10.1016/0006-2952(73)90259-1. [DOI] [PubMed] [Google Scholar]
  6. Cook L., Sepinwall J. Behavioral analysis of the effects and mechanisms of action of benzodiazepines. Adv Biochem Psychopharmacol. 1975;(14):1–28. [PubMed] [Google Scholar]
  7. Curzon G., Green A. R. Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol. 1970 Jul;39(3):653–655. doi: 10.1111/j.1476-5381.1970.tb10373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fletcher A., Fowler L. J. gamma-Aminobutyric acid metabolism in rat brain following chronic oral administration of ethanolamine O-sulphate. Biochem Pharmacol. 1980 Jun 1;29(11):1451–1454. doi: 10.1016/0006-2952(80)90592-4. [DOI] [PubMed] [Google Scholar]
  9. Forchetti C. M., Meek J. L. Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus. Brain Res. 1981 Feb 9;206(1):208–212. doi: 10.1016/0006-8993(81)90118-9. [DOI] [PubMed] [Google Scholar]
  10. Gallager D. W. Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus. Eur J Pharmacol. 1978 May 15;49(2):133–143. doi: 10.1016/0014-2999(78)90069-9. [DOI] [PubMed] [Google Scholar]
  11. Geller I., Blum K. The effects of 5-HTP on para-Chlorophenylalanine (p-CPA) attenuation of "conflict" behavior. Eur J Pharmacol. 1970 Mar;9(3):319–324. doi: 10.1016/0014-2999(70)90229-3. [DOI] [PubMed] [Google Scholar]
  12. Graeff F. G. Tryptamine antagonists and punished behavior. J Pharmacol Exp Ther. 1974 May;189(2):344–350. [PubMed] [Google Scholar]
  13. KOECHLIN B. A., SCHWARTZ M. A., KROL G., OBERHANSLI W. THE METABOLIC FATE OF C14-LABELED CHLORDIAZEPOXIDE IN MAN, IN THE DOG, AND IN THE RAT. J Pharmacol Exp Ther. 1965 Jun;148:399–411. [PubMed] [Google Scholar]
  14. Kerwin R. W., Pycock C. J. The effect of some putative neurotransmitters on the release of 5-hydroxytryptamine and gamma-aminobutyric acid from slices of the rat midbrain raphe area. Neuroscience. 1979;4(9):1359–1365. doi: 10.1016/0306-4522(79)90163-5. [DOI] [PubMed] [Google Scholar]
  15. LLOYD A. G., TUDBALL N., DODGSON K. S. Infrared studies on sulphate esters. III. O-Sulphate esters of alcohols, amino alcohols and hydroxylated amino acids. Biochim Biophys Acta. 1961 Sep 30;52:413–419. doi: 10.1016/0006-3002(61)90397-3. [DOI] [PubMed] [Google Scholar]
  16. Maickel R. P., Cox R. H., Jr, Saillant J., Miller F. P. A method for the determination of serotonin and norepinephrine in discrete areas of rat brain. Int J Neuropharmacol. 1968 May;7(3):275–281. doi: 10.1016/0028-3908(68)90034-8. [DOI] [PubMed] [Google Scholar]
  17. Paul C. J., Whitehouse L. W. Metabolic basis for the supra-additive effect of the ethanol-diazepam combination in mice. Br J Pharmacol. 1977 May;60(1):83–90. doi: 10.1111/j.1476-5381.1977.tb16751.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Robichaud R. C., Sledge K. L. The effects of p-chlorophenylalanine on experimentally induced conflict in the rat. Life Sci. 1969 Sep 1;8(17):965–969. doi: 10.1016/0024-3205(69)90427-5. [DOI] [PubMed] [Google Scholar]
  19. SCOTT E. M., JAKOBY W. B. Soluble gamma-aminobutyric-glutamic transaminase from Pseudomonas fluorescens. J Biol Chem. 1959 Apr;234(4):932–936. [PubMed] [Google Scholar]
  20. Schoenfeld R. I. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat. Science. 1976 May 21;192(4241):801–803. [PubMed] [Google Scholar]
  21. Tye N. C., Everitt B. J., Iversen S. D. 5-Hydroxytryptamine and punishment. Nature. 1977 Aug 25;268(5622):741–743. doi: 10.1038/268741a0. [DOI] [PubMed] [Google Scholar]
  22. Wise C. D., Berger B. D., Stein L. Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science. 1972 Jul 14;177(4044):180–183. doi: 10.1126/science.177.4044.180. [DOI] [PubMed] [Google Scholar]
  23. de Silva J. A., Bekersky I., Puglisi C. V., Brooks M. A., Weinfeld R. E. Determination of 1,4-benzodiazepines and -diazepin-2-ones in blood by electron-capture gas-liquid chromatography. Anal Chem. 1976 Jan;48(1):10–19. doi: 10.1021/ac60365a037. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES